Development of Vaginal Lactobacilli for Mucosal Delivery of a Topical Microbicide, Cyanovirin-N (CV-N) by unknown
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open AccessOral presentation
Development of Vaginal Lactobacilli for Mucosal Delivery of a 
Topical Microbicide, Cyanovirin-N (CV-N)
Laurel Lagenaur*‡1, Xiaowen Liu1, David A Simpson1, Kirsten Essenmacher1, 
Courtney Parker1, Chia-Hwa Chang1, Daniel Tsai1, Srinivas Rao2, 
Dean Hamer3, Thomas P Parks1, Peter P Lee1,4 and Qiang Xu1
Address: 1Osel, Inc., 1800 Wyatt Dr., Ste. 14, Santa Clara, CA 95054 USA, 2Laboratory Animal Medicine, VRC, NIH, Bethesda, MD 20892 USA, 
3National Cancer Institute, NIH, Bethesda, MD 20892 USA and 4Dept. of Medicine, Stanford University, Stanford, CA 94305 USA
Email: Laurel Lagenaur* - llagenaur@oselinc.com
* Corresponding author    ‡Presenting author    
Background
Women are particularly at risk of HIV infection, therefore,
female initiated strategies are essential to curtail the HIV/
AIDS pandemic worldwide.
Material and Methods
We developed a live topical microbicide, which is an
H2O2-producing Lactobacillus jensenii, a natural compo-
nent of the vaginal microflora, as a delivery vehicle for the
potent HIV inhibitor, cyanovirin-N (CV-N).
Results
The optimized CV-N expression cassette was stably inte-
grated in single copy into the lactobacillus bacterial chro-
mosome, and resolved from extraneous plasmid DNA
and antibiotic resistance determinants. The L. jensenii-
expressed CV-N dramatically decreased CCR5-trophic
HIVBaL infectivity in vitro, with an IC50 of 0.3 nM. Histolog-
ical examination of CD1 mice, which were intra-vaginally
inoculated with L. jensenii expressing CV-N, revealed that
L. jensenii was associated with keratinized epithelium
present during estrus or free in the vaginal lumen and
secreted full-length CV-N in vivo.
Conclusion
This live microbicide represents a major step towards
developing inexpensive, durable protein-based microbi-
cides to address the urgent need for female-controlled
approaches to block the heterosexual transmission of
HIV.
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